| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |